Morgan Stanley’s IceCure Medical ICCM Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCM
AC
CIA
WAM
HF
GCM
KFG
LAS
Morgan Stanley's ICCM Position: Q1 2026 in Review
Morgan Stanley increased its IceCure Medical (ICCM) stake by 240% in Q1 2026, buying an estimated $7.31K and bringing the position to 567 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #7129.
Morgan Stanley first reported a position in ICCM in Q4 2021 and has held it in 11 quarters since. The position peaked at $13K in Q4 2023. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.
- Morgan Stanley held 567 shares of IceCure Medical worth $5.12K as of Q1 2026.
- Morgan Stanley bought 400 IceCure Medical shares in Q1 2026, an estimated $7.31K.
- IceCure Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7129 holding.
- Morgan Stanley first reported a position in IceCure Medical in Q4 2021 and has held it in 11 quarters since.
- Morgan Stanley's IceCure Medical position peaked at $13K in Q4 2023.
- 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.